Back to AMLX
TCG Crossover Management, LLC → AMLX
TCG Crossover Management, LLC AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$181.7M
Q3 2026
Peak value
$181.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $75.4M |
| Q1 2026 | $86.8M |
| Q2 2026 | $112.1M |
| Q3 2026 | $181.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $181.7M | 6.24M | — | — |
| Q2 2026 | $112.1M | 6.24M | — | — |
| Q1 2026 | $86.8M | 6.24M | — | — |
| Q4 2025 | $75.4M | 6.24M | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.5M
$153.4M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC